Foresite Capital Fund IV, L.P. → Quantum-Si Inc QSIAW

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

6 transactions

0 buys · 6 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-05-29

DTC 1.00

5,067 shares short · -31.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-22	Hawkins Jeffrey Alan	director, officer	Sale	9,709	$0.76	$7K
2026-09-22	Keyes Jeffry R.	officer	Sale	2,493	$0.76	$2K
2026-09-22	LaPointe Christian	officer	Sale	4,721	$0.76	$4K
2026-09-21	Hawkins Jeffrey Alan	director, officer	Sale	20,143	$0.76	$15K
2026-09-21	Keyes Jeffry R.	officer	Sale	5,172	$0.76	$4K
2026-09-21	LaPointe Christian	officer	Sale	9,795	$0.76	$7K

Other 13D/G Filings on Quantum-Si Inc

Filed	Form	Filer	Stake	Shares
2026-08-28	SCHEDULE 13D/A	ROTHBERG JONATHAN M	100.00%	14,376,415	view →
2021-06-14	SC	Flynn James E	—	—	view →

Other Filings by Foresite Capital Fund IV, L.P.

Filed	Form	Issuer	Stake	Shares
2023-02-22	SC	Kinnate Biopharma Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →